Cosmo Pharmaceuticals N.V. (SWX: COPN)

Cosmo Pharmaceuticals Revenue

Cosmo Pharmaceuticals had revenue of 136.24M EUR in the half year ending June 30, 2024, with 228.19% growth. This brings the company's revenue in the last twelve months to 185.36M, up 77.82% year-over-year. In the year 2023, Cosmo Pharmaceuticals had annual revenue of 92.78M, down -9.12%.

• Revenue (ttm): 185.36M EUR
• Revenue Growth: +77.82%
• P/S Ratio: 6.73
• Revenue / Employee: 570.33K EUR
• Employees: 325
• Market Cap: 1.20B CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	92.78M	-9.31M	-9.12%
Dec 31, 2022	102.09M	37.02M	56.88%
Dec 31, 2021	65.07M	4.13M	6.77%
Dec 31, 2020	60.95M	-1.55M	-2.47%
Dec 31, 2019	62.50M	-3.12M	-4.76%